BridgeMD
New treatment option for Posttraumatic Stress Disorder
Official title Mitigating PTSD-CUD After Sexual Assault
ClinicalTrials.gov ID: NCT05989841
What this study is testing
- What it's testing
- 683,000 women are sexually assaulted annually in the United States, half of whom develop chronic posttraumatic stress disorder (PTSD) and thus have markedly increased risk for cannabis use disorder (CUD). The current proposal will test the acceptability, initial efficacy, and mechanisms underlying a novel digital therapeutic targeting risk for PTSD-CUD, which could address the critical need for PTSD-CUD prevention for the 100,000 women who annually present for emergency care after sexual assault.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Women sexual assault survivors presenting for emergency care \<72 hours post-assault at 1 of our 4 emergency care sites
- English speakers
- 18+ years of age
- Able to provide informed consent
- Have a smartphone with continuous service \>1 year
You likely can't join if
- Inability to provide informed consent (e.g., serious injury preventing the ability to hear, speak, or see to consent and participate, or other causes...
- Prisoner
- Currently pregnant
- Lives with assailant and plans to continue to do so
- Admitted patient
- No mailing address
See the full eligibility criteria
- Women sexual assault survivors presenting for emergency care \<72 hours post-assault at 1 of our 4 emergency care sites
- English speakers
- 18+ years of age
- Able to provide informed consent
- Have a smartphone with continuous service \>1 year
- Report \>1x/weekly cannabis use on a substance use screener
- Report elevated AS (\>17 on the Anxiety Sensitivity Index-3)
- Inability to provide informed consent (e.g., serious injury preventing the ability to hear, speak, or see to consent and participate, or other causes (e.g., diagnosed cognitive deficits, diagnosed dementia, asleep at...
- Prisoner
- Currently pregnant
- Lives with assailant and plans to continue to do so
- Admitted patient
- No mailing address
- Previously enrolled
- No sexual assault nurse examiner (SANE) examination
- Reporting current plan and intent for suicide or homicide
- Does not understand written and spoken English
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
- Las Vegas, Nevada, United States
- Chapel Hill, North Carolina, United States
- Smithfield, North Carolina, United States
- Tulsa, Oklahoma, United States
- Austin, Texas, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States; Las Vegas, Nevada, United States; Chapel Hill, North Carolina, United States; Smithfield, North Carolina, United States; Tulsa, Oklahoma, United States; Austin, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.